BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 29288899)

  • 1. Identification of the cognate peptide-MHC target of T cell receptors using molecular modeling and force field scoring.
    Lanzarotti E; Marcatili P; Nielsen M
    Mol Immunol; 2018 Feb; 94():91-97. PubMed ID: 29288899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and dynamic control of T-cell receptor specificity, cross-reactivity, and binding mechanism.
    Baker BM; Scott DR; Blevins SJ; Hawse WF
    Immunol Rev; 2012 Nov; 250(1):10-31. PubMed ID: 23046120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor.
    Sant'Angelo DB; Robinson E; Janeway CA; Denzin LK
    Eur J Immunol; 2002 Sep; 32(9):2510-20. PubMed ID: 12207335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling alternative binding registers of a minimal immunogenic peptide on two class II major histocompatibility complex (MHC II) molecules predicts polarized T-cell receptor (TCR) contact positions.
    Murray JS; Fois SD; Schountz T; Ford SR; Tawde MD; Brown JC; Siahaan TJ
    J Pept Res; 2002 Mar; 59(3):115-22. PubMed ID: 11985705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of a dominant T cell response to an HIV reverse transcriptase 8-mer epitope presented by the protective allele HLA-B*51:01.
    Motozono C; Kuse N; Sun X; Rizkallah PJ; Fuller A; Oka S; Cole DK; Sewell AK; Takiguchi M
    J Immunol; 2014 Apr; 192(7):3428-34. PubMed ID: 24600035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of peptide interaction with MHC creates TCR partial agonists.
    Ryan KR; McNeil LK; Dao C; Jensen PE; Evavold BD
    Cell Immunol; 2004 Jan; 227(1):70-8. PubMed ID: 15051516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T cells expressing affinity-matured TCR display accelerated responses but fail to recognize low density of MHC-peptide antigen.
    Thomas S; Xue SA; Bangham CR; Jakobsen BK; Morris EC; Stauss HJ
    Blood; 2011 Jul; 118(2):319-29. PubMed ID: 21606483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering CD4
    Kisielow J; Obermair FJ; Kopf M
    Nat Immunol; 2019 May; 20(5):652-662. PubMed ID: 30858620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based prediction of T cell receptor:peptide-MHC interactions.
    Bradley P
    Elife; 2023 Jan; 12():. PubMed ID: 36661395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103).
    Reay PA; Kantor RM; Davis MM
    J Immunol; 1994 Apr; 152(8):3946-57. PubMed ID: 7511662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell receptor signaling is limited by docking geometry to peptide-major histocompatibility complex.
    Adams JJ; Narayanan S; Liu B; Birnbaum ME; Kruse AC; Bowerman NA; Chen W; Levin AM; Connolly JM; Zhu C; Kranz DM; Garcia KC
    Immunity; 2011 Nov; 35(5):681-93. PubMed ID: 22101157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A structural-based machine learning method to classify binding affinities between TCR and peptide-MHC complexes.
    Dhusia K; Su Z; Wu Y
    Mol Immunol; 2021 Nov; 139():76-86. PubMed ID: 34455212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular challenges imposed by MHC-I restricted long epitopes on T cell immunity.
    Josephs TM; Grant EJ; Gras S
    Biol Chem; 2017 Aug; 398(9):1027-1036. PubMed ID: 28141543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structural interactions between T cell receptors and MHC-peptide complexes place physical limits on self-nonself discrimination.
    Wucherpfennig KW
    Curr Top Microbiol Immunol; 2005; 296():19-37. PubMed ID: 16329190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognate peptide-MHC complexes are expressed as tightly apposed nanoclusters in virus-infected cells to allow TCR crosslinking.
    Ferez M; Castro M; Alarcon B; van Santen HM
    J Immunol; 2014 Jan; 192(1):52-8. PubMed ID: 24307729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCRpMHCmodels: Structural modelling of TCR-pMHC class I complexes.
    Jensen KK; Rantos V; Jappe EC; Olsen TH; Jespersen MC; Jurtz V; Jessen LE; Lanzarotti E; Mahajan S; Peters B; Nielsen M; Marcatili P
    Sci Rep; 2019 Oct; 9(1):14530. PubMed ID: 31601838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How an alloreactive T-cell receptor achieves peptide and MHC specificity.
    Wang Y; Singh NK; Spear TT; Hellman LM; Piepenbrink KH; McMahan RH; Rosen HR; Vander Kooi CW; Nishimura MI; Baker BM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(24):E4792-E4801. PubMed ID: 28572406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engagement of a T cell receptor by major histocompatibility complex irrespective of peptide.
    Vessey SJ; Barouch DH; McAdam SN; Tussey LG; Davenport MA; O'Callaghan CA; Bell JI; McMichael AJ; Jakobsen BK
    Eur J Immunol; 1997 Apr; 27(4):879-85. PubMed ID: 9130639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between computational alanine scanning and per-residue binding free energy decomposition for protein-protein association using MM-GBSA: application to the TCR-p-MHC complex.
    Zoete V; Michielin O
    Proteins; 2007 Jun; 67(4):1026-47. PubMed ID: 17377991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TCR contact residue hydrophobicity is a hallmark of immunogenic CD8+ T cell epitopes.
    Chowell D; Krishna S; Becker PD; Cocita C; Shu J; Tan X; Greenberg PD; Klavinskis LS; Blattman JN; Anderson KS
    Proc Natl Acad Sci U S A; 2015 Apr; 112(14):E1754-62. PubMed ID: 25831525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.